PoreMeth2 for decoding the evolution of methylome alterations with nanopore sequencing

  1. Alberto Magi1
  1. 1Department of Information Engineering, University of Florence, 50139 Florence, Italy;
  2. 2Department of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, 50139 Florence, Italy;
  3. 3Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, 20141 Milano, Italy;
  4. 4Institute of Informatics and Telematics (IIT), CNR, 56124 Pisa, Italy;
  5. 5Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy
  1. 6 These authors contributed equally to this work.

  • Corresponding authors: albertomagi{at}gmail.com, gianluca.mattei{at}unifi.it, marta.baragli{at}unifi.it
  • Abstract

    In epigenetic analysis, the identification of differentially methylated regions (DMRs) typically involves the detection of consecutive CpGs groups that show significant changes in their average methylation levels. However, the methylation state of a genomic region can also be characterized by a mixture of patterns (epialleles) with variable frequencies, and the relative proportions of such patterns can provide insights into its mechanisms of formation. Traditional methods based on bisulfite conversion and high-throughput sequencing, such as Illumina, owing to the read size (150 bp) allow epiallele frequency analysis only in high CpG density regions, limiting differential methylation studies to just 50% of the human methylome. Nanopore sequencing, with its long reads, enables the analysis of epiallele frequency across both high and low CpG density regions. Here, we introduce a novel computational approach, PoreMeth2, an R library that integrates epiallelic diversity and methylation frequency changes from nanopore data to identify DMRs, providing insights into their possible mechanisms of formation, and annotate them to genic and regulatory elements. We apply PoreMeth2 to cancer and glial cell data sets, providing evidence of its advance over other state-of-the-art methods and demonstrating its ability to distinguish epigenomic alterations with a strong impact on gene expression from those with weaker effects on transcriptional activity.

    Footnotes

    • Received November 22, 2024.
    • Accepted September 11, 2025.

    This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see https://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

    | Table of Contents

    Preprint Server